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Problem And Need
•
•
•
•

Chronic pain can be described as ongoing or recurrent pain, lasting beyond the usual
course of acute illness or injury or more than 3 to 6 months, and which adversely affects the
individual’s well-being. (ACPA)
Historically, opioids have been used to treat pain
Opioids can be helpful in the short-term, but long-term use leads to tolerance,
dependence, and the risk of diversion and overdose. There is also evidence that opiates
provide little to no gain in actual functioning and inadequate relief of pain concerns
Providers and patients need education and support in decreasing opioid use and providing
alternative modalities for chronic pain treatment
2

Public Health Cost
• In the U.S. persistent pain impacts 100 million adults and costs from $560 to
$635 billion annually.

• Costs include direct medical cost, disability, and lost wages and productivity
• The costs of persistent pain exceed the economic costs of the six most
costly major diagnoses—cardiovascular diseases ($309 billion); neoplasms
($243 billion); injury and poisoning ($205 billion); endocrine, nutritional, and
metabolic diseases ($127 billion); digestive system diseases ($112 billion);
and respiratory system diseases ($112 billion)
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Public Health Cost
• Opioid use, even when medically
indicated, has its own related public
health costs

• Opioids create risk for accidental
overdose and death
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Community Perspective
Rodger Kessler, PHD, Berlin Family Practice

•
•
•

•

Generation of people addicted to opiates, and they are upset that doctors are now
decreasing their medications after years of prescribing them for pain. More information will
not necessarily change their behavior – we have to treat the addiction.
Berlin Family practice could benefit from better coordination between MDs and
Community Health Team regarding linkages to community resources.
The probability of success is low that patients can substantially lower or eliminate their
dependence on opiates for chronic pain, but success is greater with community-based
therapy.
Opioid Toolkit developed by Vermont providers is a model for how to approach use of
narcotics
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Community Perspective
Jacqueline M. S. Jancaitis, PT, The RehabGYM, Barre, VT
• Assessment based on functional capacity rather than “how much” pain they feel. Focus
placed on gaining function that will improve quality of life.
• Ongoing discussion about medications/drugs used, functional improvements appreciated
during PT, pain experienced, and referral back to doctor for possible medication
adjustment.
• Mental Health counseling one of the most important ways to assist physical therapy.
“Occasionally someone is appropriate for yoga or meditation, but mostly it seems coping
strategies are more appropriate.”
• “Patient's who get off narcotics report to me that they're pain is very different after they
are off the medication. A lot of them get stuck in a pain cycle on the medication and then
when they are off the pain is better for no other reason.”
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Intervention
• Literature Review
• Patient information sheet explaining role, limitations, and risks of opioid
medication for chronic pain

• Provider Information sheet regarding Milligram Morphine Equivalent
Conversion and evidence about opioid dosage and safety

• Survey for providers about intervention
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Patient
Information
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Provider Information
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Response
• Survey was sent to Berlin Family
Practice Providers for feedback
and suggestions for
improvement

• Responses will be reviewed and
guide changes to intervention
and recommendations for future
projects.
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Evaluation and Limitations
•
•
•
•
•

Provider survey responses will inform practicality of intervention
Tracking the number of information sheets given will assess its clinical utility
Following practice-wide trends will demonstrate progress on this issue. Indicators may
include the number of patients using opiates for chronic pain and the dosage or Milligram
Morphine Equivalents prescribed
It will be difficult to evaluate role of the information sheet in reducing opiate use vs.
motivational interviewing and guidance from the provider.
Additionally, many other variables will impact patient response such as access to
complimentary treatment, level of social support, housing, access to food, and
transportation.
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Recommendations
•

Practice-wide adoption of recommendations from:
Improving Opioid Prescribing: Sustainable Solutions for Vermont. Opioid Prescription
Management Toolkit for Chronic Pain: Practice Fast Track
Connie van Eeghen, DrPH, Charles D. MacLean, MD, Amanda G. Kennedy, PharmD, BCP
• Provider and Community Health Team meeting(s) to plan specific actions that can increase
the capacity of the community health team for connecting chronic pain patients with
community-based resources and services.
• Continue to educate patients about the risks associated with opioid use and engage in realistic
goal-setting for functioning with chronic pain
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